Surgical site infection after pelvic bone and soft tissue sarcoma resection: Risk factors, microbiology, and impact of extended postoperative antibiotic prophylaxis
Journal of Surgical Oncology · 2023-08 · 128 (2) · 344-349
DOI: 10.1002/jso.27271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 03.04.2023. Verfasst von Samuel Bensaid und 10 weiteren Autor:innen. Beteiligte Einrichtung: Équipe Mobile d'Infectiologie, AP-HP, APHP-CUP, Hôpital Cochin, Paris, France. Hauptthemen laut MEDLINE: Pelvic Bones, Sarcoma. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background
Pelvic bone and/or soft tissue sarcoma removal surgeries are associated with a high rate of surgical site infection (SSI). The recommended antibiotic prophylaxis (ABP) duration is 24−48 h. We aimed to assess the impact of extended ABP (5 days) on the SSI rate and describe the microbiology of SSI in bone and/or soft tissue pelvic sarcomas.
Methods
We retrospectively included all consecutive patients who underwent pelvic bone and/or soft tissue sarcoma removal surgery between January 2010 and June 2020.
Results
We analyzed 146 patients with pelvic bone (45, 31%) or soft tissue (101, 69%). Sixty patients (41%) developed SSI. SSI occurred in 13/28 (46.4%) in the extended ABP group versus 47/118 (39.8%) in the standard group ( p = 0.53). In multivariable analysis, risk factors for SSI were surgery duration (OR: 1.94 [1.41−2.92] per h), stay in postoperative ICU for more than 2 days (12.0 [2.8−61.3]), and shred or autologous skin flap (39.3 [5.8−409.5]). Extended ABP was not associated with SSI. SSI were mainly polymicrobial with Enterobacterales (57.4%) and Enterococcus (45%). Conclusions and Discussion Pelvic bone and/or soft tissue sarcoma removal surgery is highly prone to postoperative infection. Extending the ABP to 5 days does not reduce the level of SSI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Équipe Mobile d'Infectiologie, AP-HP, APHP-CUP, Hôpital Cochin, Paris, France.
- Faculté de Médecine, Université de Paris, Paris, France.
- Service de bactériologie, AP-HP, APHP-CUP, Hôpital Cochin, Paris, France.
- Centre de référence infection ostéo-articulaires complexes (CRIOAC), AP-HP, APHP-CUP, Hôpital Cochin, Paris, France.
- Service d'anesthésie, AP-HP, APHP-CUP, Hôpital Cochin, Paris, France.
- Institut Pasteur, Inserm U1117, Biology of Infection Unit, Paris, France.
Zitieren
APA
Bensaid, S., Contejean, A., Morand, P., Enser, M., Eyrolle, L., Charlier, C., Kernéis, S., Anract, P., Biau, D., Canouï, E., & Other Members of the CRIOACochin Group (2023). Surgical site infection after pelvic bone and soft tissue sarcoma resection: Risk factors, microbiology, and impact of extended postoperative antibiotic prophylaxis. Journal of Surgical Oncology, 128(2), 344-349. https://doi.org/10.1002/jso.27271
Vancouver
Bensaid S, Contejean A, Morand P, Enser M, Eyrolle L, Charlier C, et al. Surgical site infection after pelvic bone and soft tissue sarcoma resection: Risk factors, microbiology, and impact of extended postoperative antibiotic prophylaxis. Journal of Surgical Oncology. 2023;128(2):344-349. doi:10.1002/jso.27271
BibTeX
@article{Bensaid2023,
author = {Bensaid, Samuel and Contejean, Adrien and Morand, Philippe and Enser, Maya and Eyrolle, Luc and Charlier, Caroline and Kernéis, Solen and Anract, Philippe and Biau, David and Canouï, Etienne and Other Members of the CRIOACochin Group, Other Members of the CRIOACochin Group},
title = {Surgical site infection after pelvic bone and soft tissue sarcoma resection: Risk factors, microbiology, and impact of extended postoperative antibiotic prophylaxis},
journal = {Journal of Surgical Oncology},
year = {2023},
volume = {128},
number = {2},
pages = {344--349},
doi = {10.1002/jso.27271}
}
EUVIMED